Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection..
Share this article
Corporate
Score 75
Bullish
A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved
Mar 19, 2026 18:42 UTC
NVO, LLY, XLP, XLV
Short term
Related Articles
Score 35
AI wants to spend your money for you. Should you trust it?
Mar 19, 19:55
Score 65
Tesla’s Stock Remains Calm Amid Uncertainty Over Robotaxis and Custom Chips
Mar 19, 19:29
Score 75
The Texas Stock Exchange Lures Leadership From Nasdaq, NYSE as it Targets Listings
Mar 19, 19:25
Score 85
Bearish
Figma Stock Slumps 11% in Two Days After Google Launches AI-Powered 'Vibe Design'
Mar 19, 19:01
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.